Results 51 to 60 of about 28,700 (297)

Visible‐Light Photo‐Iniferter Polymerization of Molecularly Imprinted Polymers for Direct Integration with Nanotransducers

open access: yesSmall Methods, EarlyView.
This study overcomes the challenges of integrating MIPs with nanostructured transducers for chemical sensing. It demonstrates precise MIP deposition on nanoporous silica (PSiO2) via controlled radical photopolymerization, achieving uniform thin films.
Tiziano Di Giulio   +8 more
wiley   +1 more source

Incidence of postoperative retinal detachment and bacterial endophthalmitis in the Swedish national paediatric cataract register and associated risk factors

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To investigate the incidence and risk factors of retinal detachment (RD) and bacterial endophthalmitis in a cohort of children who underwent cataract surgery before the age of eight. Methods Data was retrieved from the Swedish national paediatric cataract register.
Arzu Seyhan Karatepe Hashas   +8 more
wiley   +1 more source

A Cutaneous Vascular Neoplasm With an EWSR1‐NFATC2 Translocation—Contributing to the Spectrum of Vascular Lesions Characterized by NFATC‐Related Fusions

open access: yesJournal of Cutaneous Pathology, EarlyView.
ABSTRACT Recently, a distinct subgroup of vascular neoplasms has been identified, characterized by NFATC‐related fusions. Although existing literature is limited, these lesions histologically show a variable appearance with a tendency for local recurrence but not distant spread.
B. Schurink   +3 more
wiley   +1 more source

Topical Timolol Inhibits Corneal Neovascularization in Rabbits [PDF]

open access: yes, 2017
Timolol is a non-selective beta-adrenergic antagonist that is similar to propranolol. The mechanism through which these drugs act on the regression of neovascularization is largely unknown.
Farrahi, Fereydoun   +5 more
core   +4 more sources

A patient preference comparison of Azarga™ (brinzolamide/timolol fixed combination) vs Cosopt® (dorzolamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension

open access: yesClinical Ophthalmology, 2008
Thomas K Mundorf1, Steven H Rauchman2, Robert D Williams3, Ricardo Notivol4, Brinzolamide/Timolol Preference Study Group51Mundorf Eye Center, Charlotte, NC, USA; 2North Valley Eye Medical Group, Mission Hills, CA, USA; 3Taustine Eye Center, Louisville ...
Thomas K Mundorf   +4 more
doaj  

Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study. [PDF]

open access: yes, 2016
PURPOSE: To compare the intraocular pressure (IOP)-lowering effect of latanoprostene bunod (LBN) 0.024% with timolol maleate 0.5% in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT).
Martin, Keith R   +5 more
core   +1 more source

Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension : Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment [PDF]

open access: yes, 2022
Funding Information: Sponsorship for this study, publication fees (Rapid Service and Open Access), and medical writing fees were provided by Santen SA.
Kirwan, James   +4 more
core   +1 more source

Association of migraine treatments with reduced ischemic stroke risk: Evidence from two large‐scale real‐world data analyses

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To compare the risk of ischemic stroke in patients with migraine treated with first‐line medications, including valproate, topiramate, metoprolol, timolol, or propranolol, versus those not receiving these treatments, using data from two large electronic health records datasets. Background The impact of first‐line migraine medications
Eugene Jeong   +2 more
wiley   +1 more source

Two Stability Indicating Chromatographic Methods: TLC Densitometric versus HPLC Method for the Simultaneous Determination of Brinzolamide and Timolol Maleate in Ophthalmic Formulation in the Presence of Probable Carcinogenic Oxidative Degradation Product of Timolol Maleate

open access: yesSeparations, 2023
A comparative study between two stability-indicating chromatographic methods for the assay of brinzolamide and timolol maleate in the co-existence of the probable carcinogenic oxidative degradation product of timolol maleate in their ophthalmic ...
Asmaa A. Mandour   +4 more
doaj   +1 more source

Pharmaceutical treatment of primary open angle glaucoma [PDF]

open access: yes, 2021
Background: Glaucoma is a progressive, irreversible optic neuropathy that results in serious vision loss and blindness. This review aimed to summarize key concepts of primary open angle glaucoma (POAG) pharmaceutical treatment trials over the last decade.
Al-Namaeh , Mashael
core   +2 more sources

Home - About - Disclaimer - Privacy